- Report
- August 2024
- 300 Pages
Global
From €2520EUR$2,655USD£2,126GBP
- Book
- September 2023
- 3456 Pages
- Book
- March 2023
- 3792 Pages
- Book
- February 2019
- 2832 Pages
- Book
- April 2018
- 420 Pages
- Book
- January 2018
- 296 Pages
- Book
- March 2017
- 250 Pages
- Book
- February 2016
- 480 Pages
- Book
- April 2025
- 256 Pages
- Book
- October 2023
- 4100 Pages
- Book
- February 2022
- 1024 Pages
Global
- Book
- February 2022
- 1024 Pages
Global

The Clinical Microbiology market within the In Vitro Diagnostics (IVD) sector is a rapidly growing field. It is focused on the development and production of diagnostic tests and instruments used to detect and identify microorganisms, such as bacteria, viruses, fungi, and parasites. These tests are used to diagnose and monitor infectious diseases, as well as to detect and monitor antibiotic resistance. Clinical Microbiology tests are used in a variety of settings, including hospitals, laboratories, and point-of-care settings.
The Clinical Microbiology market is driven by the increasing prevalence of infectious diseases, the emergence of new pathogens, and the need for rapid and accurate diagnosis. Additionally, the increasing demand for personalized medicine and the development of new technologies are expected to drive the market in the future.
Some of the major companies in the Clinical Microbiology market include Abbott Laboratories, Becton Dickinson, bioMérieux, Cepheid, Danaher Corporation, Hologic, Qiagen, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more